Q3 2024 Holdings
Filed 2024-11-14 | 11 holdings | $582.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $213.9M | 5,954,069 | 36.7% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $196.4M | 11,831,461 | 33.7% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $57.3M | 8,677,951 | 9.8% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $53.3M | 4,866,449 | 9.2% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $53.0M | 2,339,961 | 9.1% |
| Engene Holdings Inc(ENGNW) | W EXP 10/31/2028 | 29286M113 | $6.0M | 2,878,148 | 1.0% |
| Achilles Therapeutics PLC(698) | SPONSORED ADS | 00449L102 | $2.4M | 2,390,050 | 0.4% |